immune system
• in the skin of diphtheria toxin- and IMQ-treated mice
|
• in the skin of diphtheria toxin- and IMQ-treated mice
|
• decreased alpha-beta T cells in the skin of diphtheria toxin- and IMQ-treated mice
|
• in the skin of diphtheria toxin- and IMQ-treated mice
|
• in diphtheria toxin- and IMQ-treated mice
|
• despite normal monocyte numbers in the blood, LPS-treated mice fail to exhibit an accumulation of CD11c+MHCII+DC-SIGN/CD209+CD14+ cells in the skin lymph nodes unlike wild-type mice
|
• mice treated with antibiotic, then diphtheria toxin (DTR) and infected with non-invasive Salmonella exhibit decreased bacterial titers in the mesenteric lymph nodes as compared to DTR-untreated controls
|
hematopoietic system
• in the skin of diphtheria toxin- and IMQ-treated mice
|
• in the skin of diphtheria toxin- and IMQ-treated mice
|
• decreased alpha-beta T cells in the skin of diphtheria toxin- and IMQ-treated mice
|
• in the skin of diphtheria toxin- and IMQ-treated mice
|
homeostasis/metabolism
• mice treated with diphtheria toxin and IMQ are protected from psoriasis development with decreased ear swelling and numbers of leukocytes, neutrophils and gamma-delta and alpha-beta T cells in the skin compared with wild-type mice
|